Copper Balance in Healthy Participants Administered ALXN1840
Clinical trial NCT04594252 · COMPLETED
Trial details
- NCT number
- NCT04594252
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2020-11-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.